ImmuneOncia Therapeutics Revenue

ImmuneOncia Therapeutics had revenue of 715.75M KRW in the twelve months ending September 30, 2025. In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M with 495.04% growth.

Revenue (ttm)

715.75M

Revenue Growth

+495.04%

P/S Ratio

757.45

Revenue / Employee

n/a

Employees

n/a

Market Cap

542.15B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	654.54M	544.54M	495.04%
Dec 31, 2023	110.00M	-7.62B	-98.58%
Dec 31, 2022	7.73B	7.70B	21,413.30%
Dec 31, 2021	35.95M	33.45M	1,337.90%
Dec 31, 2020	2.50M	1.00M	66.67%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CellBion	2.13B
Myung In Pharmaceutical LTD.	283.31B
DAE HWA Pharmaceutical	149.47B
NOVAREX	385.76B
Vivozon Pharmaceutical	66.40B
Organoidsciences	2.55B
OPTUS Pharmaceutical	87.58B
GREEN CROSS WellBeing	151.06B

Revenue Rankings